Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Compounded GLP-1 A clinician-reviewed weight loss protocol utilizing Compounded Semaglutidethe same active ingredient in Ozempic and Wegovy.* Designed to quiet appetite signals, slow gastric emptying, and support sustainable metabolic correction
Song LJ, Luo H, Fan WH, Wang GP, Yin XR, Shen S, et al
This results in improved half-life and increased activity due to extended bioavailability in the body
In comparison to other GLP-1RAs, semaglutide was found to produce up to three times higher weight loss in type 2 diabetic patients and up to twice as much weight loss in obese patients, with some patients losing up to 15 kg
Dispensing When prescribed, BPC-157 is dispensed by a licensed compounding pharmacy with provider instructions not bought from unregulated research chemical vendors, where purity and contents are unverified
Diabetes Ther (2019) 10(5):187992
